Natural Killer(NK) Cell Combined With Programmed Death-1(PD-1) Antibody as Second Line Therapy for Advanced Driver Mutation Negative Non-small Cell Lung Cancer
Clinical trial NCT03958097 · COMPLETED
Trial details
- NCT number
- NCT03958097
- Sponsor
- The First Hospital of Jilin University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-17
- Primary completion
- 2020-10-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.